Bolt Biotherapeutics, Inc. - BOLT

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 26, 2026 SCHEDULE 13D/A — — — View
Feb 17, 2026 SCHEDULE 13D/A — — — View
Feb 13, 2026 SCHEDULE 13G/A Vivo Capital Fund VIII, L.P. 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A Vivo Capital Surplus Fund VIII, L.P. 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A Vivo Capital VIII, LLC 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A Vivo Panda Fund, L.P. 3.8% 72,414 View
Feb 13, 2026 SCHEDULE 13G/A Vivo Panda, LLC 3.8% 72,414 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL MANAGEMENT, LLC 3.5% 66,879 View
Nov 14, 2025 SCHEDULE 13G/A KEVIN TANG 3.5% 66,879 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL PARTNERS, LP 2.0% 37,675 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL PARTNERS INTERNATIONAL, LP 1.5% 29,204 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL PARTNERS III, INC 0.0% 0 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL PARTNERS IV, INC 0.0% 0 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL MANAGEMENT, LLC 3.5% 66,879 View
Nov 14, 2025 SCHEDULE 13G/A KEVIN TANG 3.5% 66,879 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL PARTNERS, LP 2.0% 37,675 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL PARTNERS INTERNATIONAL, LP 1.5% 29,204 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL PARTNERS III, INC 0.0% 0 View
Nov 14, 2025 SCHEDULE 13G/A TANG CAPITAL PARTNERS IV, INC 0.0% 0 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.